With low false positives and broad detection capabilities, Volition’s Nu.Q® test could reshape the $20B liquid biopsy market, as the company advances licensing talks with major diagnostic players. ...
Collaboration aims to enhance pharmaceutical innovation and expand access to high-quality healthcare solutions worldwide. ...
Strategic move strengthens Clario’s leadership in medical imaging and bolsters expertise in multiple sclerosis and neurological drug development....
Strategic Agreement Brings Evidence-Based Clinical Pathways to Radiation Oncology Workflows, Improving Care Quality and Efficiency ...
The integrated clinical chemistry and immunoassay system enhances efficiency, streamlines lab workflows, and delivers accurate diagnostics in a compact design....
Largest head-to-head TAVR study highlights Evolut’s lower bioprosthetic valve dysfunction and improved durability in patients with small aortic annulus, reinforcing clinical decision-making in transcatheter valve therapy....
Court ruling dismisses claims against Co-Diagnostics, reinforcing the company’s commitment to transparency and innovation in molecular diagnostics....
Strategic agreement integrates Optellum’s AI-powered lung nodule analysis with Volpara’s early cancer detection tools, enabling a more comprehensive approach to patient risk evaluation....
The acquisition adds the ultrasound-based TIVUS™ system to Boston Scientific’s interventional portfolio, enhancing treatment options for hypertension and expanding its presence in renal denervation therapy. ...
Early glaucoma detection, SightScore™ empowers eye care professionals with advanced genetic insights to identify high-risk individuals before symptoms appear, paving the way for proactive vision care....
